drugset / Trial / NCT07286682
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants
RandomizedSequentialDouble-blindBasic science
Summary
The purpose of this study is to evaluate the safety and tolerability of single ascending doses of UCB5285 in healthy study participants, including healthy Japanese study participants
Timeline
- Start
- 2025-12-08
- Primary completion
- 2026-12-13
- Completion
- 2026-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UCB5285 | Unknown | — | — |
Indications
No indication recorded.